How Pharma Can Navigate the Shifting Sands of Oncology Treatments

www.bcg.com

With advances in knowledge, understanding, technology, and data come fragmentation and complexity. Since the bets are big, companies need to evaluate prospects and make their investments count.

Oncology Treatments "Even on the surface, the business of cancer treatment has changed radically in less than a decade. In 2013, pharma oncology revenues totaled about $65 billion, and one company (Roche) dominated, with a handful of mega blockbuster drugs and a 40% market share. Growth has been rapid, and competition has intensified dramatically: in 2020, the top five major players, many with several mega blockbusters each, accounted for 57% of the $156 billion oncology market."